Periomegomel inf. emuls. i.v.

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Zinc Sulfate Heptahydrate 7,373 µg/ml; Sodium Acetate Trihydrate 1,77 mg/ml; Sodium Glycerophosphate Hydrate 1,871 mg/ml; Magnesium Sulfate Heptahydrate 0,774 mg/ml; Glycine 3,244 mg/ml; Valine 1,825 mg/ml; Arginine 3,622 mg/ml; Lysine Hydrochloride 2,286 mg/ml - Eq. Lysine 1,825 mg/ml; Leucine 2,304 mg/ml; Potassium Chloride 1,41 mg/ml; Serine 1,576 mg/ml; Proline 2,147 mg/ml; Alanine 6,525 mg/ml; Histidine 1,512 mg/ml; Threonine 1,327 mg/ml; Tryptophan 0,571 mg/ml; Soya Oil 8,46 mg/ml; Triglycerides Medium Chain 7,051 mg/ml; Olive Oil 7,051 mg/ml; Fish Oil Rich in Omega-3-Acids 5,641 mg/ml; Glucose Monohydrate 77,788 mg/ml - Eq. Glucose 70,691 mg/ml; Calcium Chloride Dihydrate 0,23 mg/ml; Tyrosine 0,129 mg/ml; Isoleucine 1,889 mg/ml; Methionine 1,263 mg/ml; Phenylalanine 1,77 mg/ml

Verfügbar ab:

Baxter SA-NV

ATC-Code:

B05BA10

Darreichungsform:

Emulsion for infusion

Verabreichungsweg:

Intravenous use

Therapiebereich:

Combinations

Produktbesonderheiten:

CTI Extended: 539466-01

Berechtigungsstatus:

Commercialised: No

Berechtigungsdatum:

2019-02-22